Identification of metastatic cancer in claims data

Pharmacoepidemiology and Drug Safety

Volumn 21, Issue SUPPL.2, 2012, Pages 21-28

  Nordstrom, Beth L ^a   Whyte, Joanna L ^b   Stolar, Marilyn ^a   Mercaldi, Catherine ^a   Kallich, Joel D ^b  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b AMGEN INC   (United States)

Author keywords

Claims data; Classification and regression trees; Electronic medical record data; Oncology

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CETUXIMAB; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DIPHENHYDRAMINE; DOCETAXEL; DOXORUBICIN; ERLOTINIB; FOLINIC ACID; GEMCITABINE; GLUCONATE CALCIUM; IRINOTECAN; LAPATINIB; LEUPRORELIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PACLITAXEL; PALONOSETRON; PAMIDRONIC ACID; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TRIPTORELIN; ZOLEDRONIC ACID;

ADULT; AGED; ALGORITHM; ANEMIA; ARTICLE; BILLING AND CLAIMS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; COLORECTAL CANCER; DISEASE SEVERITY; DRUG INFUSION; ELECTRONIC MEDICAL RECORD; FEMALE; GOLD STANDARD; HUMAN; IMMUNOASSAY; INTERNATIONAL CLASSIFICATION FOR NURSING PRACTICE; LUNG CANCER; LYMPH NODE BIOPSY; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MASTECTOMY; METASTASIS; PHARMACY; PHYSICIAN; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE CANCER; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; ALGORITHMS; ANTINEOPLASTIC AGENTS; DATABASES, FACTUAL; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; INSURANCE CLAIM REVIEW; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84860572877     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3247     Document Type: Article

References (19)

1. Badger SA, Brant JL, Jones C, et al. The role of surgery for pancreatic cancer: a 12-year review of patient outcome. Ulster Med J 2010; 79: 70-75.
2. Chi Z, Li S, Sheng X, et al. Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases. BMC Cancer 2011; 11: 85.
3. Garcia-Carbonero R, Capdevila J, Crespo-Herrero G, et al. Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE). Ann Oncol 2010; 21: 1794-1803.
4. Kim MK, Cho KJ, Park SI, et al. Initial stage affects survival even after complete pathologic remission is achieved in locally advanced esophageal cancer: analysis of 70 patients with pathologic major response after preoperative chemoradiotherapy. Int J Radiat Oncol Biol Phys 2009; 75: 115-121.
5. Lee PC, Mirza FM, Port JL, et al. Predictors of recurrence and disease-free survival in patients with completely resected esophageal carcinoma. J Thorac Cardiovasc Surg 2011; 141: 1196-1206.
6. Health Care Financing Administration. International Classification of Disease, 9th Revision, Clinical Modification (ICD-9-CM). US Department of Health and Human Services: Washington, DC, 1980.
7. Freeman JL, Zhang D, Freeman DH, Goodwin JS. An approach to identifying incident breast cancer cases using Medicare claims data. J Clin Epidemiol 2000; 53: 605-614.
8. Gold HT, Do HT. Evaluation of three algorithms to identify incident breast cancer in Medicare claims data. Health Serv Res 2007; 42: 2056-2069.
9. Leung KM, Hasan AG, Rees KS, Parker RG, Legorreta AP. Patients with newly diagnosed carcinoma of the breast: validation of a claim-based identification algorithm. J Clin Epidemiol 1999; 52: 57-64.
10. Penberthy L, McClish D, Manning C, Retchin S, Smith T. The added value of claims for cancer surveillance: results of varying case definitions. Med Care 2005; 43: 705-712.
11. Ramsey SD, Mandelenson MT, Etzioni R, Harrison R, Smith R, Taplin S. Can administrative data identify incident cases of colorectal cancer? A comparison of two health plans. Health Serv Outcomes Res Methodol 2004; 5: 27-37.
12. Solin LJ, Legorreta A, Schultz DJ, Levin HA, Zatz S, Goodman RL. Analysis of a claims database for the identification of patients with carcinoma of the breast. J Med Syst 1994; 18: 23-32.
13. Solin LJ, MacPherson S, Schultz DJ, Hanchak NA. Evaluation of an algorithm to identify women with carcinoma of the breast. J Med Syst 1997; 21: 189-199.
14. Cooper GS, Yuan Z, Stange KC, Amini SB, Dennis LK, Rimm AA. The utility of Medicare claims data for measuring cancer stage. Med Care 1999; 37: 706-711.
15. Nattinger AB, Laud PW, Bajorunaite R, Sparapani RA, Freeman JL. An algorithm for the use of Medicare claims data to identify women with incident breast cancer. Health Serv Res 2004; 39: 1733-1749.
16. Smith GL, Shih YC, Giordano SH, Smith BD, Buchholz TA. A method to predict breast cancer stage using Medicare claims. Epidemiol Perspect Innov 2010; 7: 1.
17. American Medical Association. Current Procedure Terminology (4th edn). American Medical Association: Chicago, IL, 1991.
18. Zhang H, Singer B. Recursive Partitioning in the Health Sciences. Springer Verlag: New York, NY, 1999.
19. Berk RA. Statistical Learning from a Regression Perspective. Springer Science+Business Media: New York, NY, 2008.